Evommune Statistics
NYSE: EVMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.04-0.20 (-2.76%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Evommune by the numbers
Evommune has a market capitalization of $291.1 million based on 41.35M shares outstanding. With trailing EPS of $-3.83, Evommune is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.2% below its 50-day average and 58.3% below its 200-day average.
Average daily trading volume is 841.65K shares, or about $5.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EVMN valuation vs. peer median
| Metric | EVMN | Peer median | Difference |
|---|---|---|---|
| Market cap | $291.10M | $282.20M | +3% |
| Avg. volume | 841.65K | 271.45K | +210% |
Peer median across 8 companies: BNTC, SPRY, GLSI, FULC, RLMD, GALT, VCRE, AVIR.
Valuation
- Market cap
- $291.10M
- Price / sales (latest FY)
- 22.39
- EPS (TTM)
- $-3.83
- Shares outstanding
- 41.35M
Price and trading
- Previous close
- 7.24
- Open
- 7.10
- Day range
- 6.96 – 7.24
- 52-week range
- 4.94 – 33.20
- 52-week change
- -62.37%
- Beta
- —
- Volume
- 549.40K
- Average volume
- 841.65K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 10, 2026
Additional statistics
- Market Cap
- 291.10M
- Forward Pe
- -2.06
- Eps
- -3.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 33.20
- Week52 Low
- 4.94
- Avg Volume
- 841.65K
- Shares Outstanding
- 41.35M
- Ma50
- 7.13
- Ma200
- 16.87
- Earnings Date
- Dec 10, 2026
- Pct From52w High
- -78.80%
- Pct From52w Low
- 42.51%